癌症（英文版）2016，Vol.56Issue(11)：585-595,11.DOI:10.1186/s40880-016-0146-7
Combined hepatocellular andcholangiocarcinoma originating fromthe same clone：a pathomolecular evidence-based study
Combined hepatocellular andcholangiocarcinoma originating fromthe same clone：a pathomolecular evidence-based study
QianZhao 1WenLongYu 2XinYuanLu 1HuiDong 1YiJinGu 1XiaSheng 1WenMingCong 1and MengChao Wu3
作者信息
- 1. Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, P. R. China
- 2. Department of Biliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, P. R. China
- 3. Department of Hepatic Surgery,Eastern Hepatobiliary Surgery Hospital, Second Military Medical University,Shanghai 200438, P. R. China
- 折叠
摘要
关键词
Combined hepatocellular and cholangiocarcinoma/Hepatocellular carcinoma/Intrahepatic cholangiocellular carcinoma/Loss of heterozygosity/Clonal origin/PrognosisKey words
Combined hepatocellular and cholangiocarcinoma/Hepatocellular carcinoma/Intrahepatic cholangiocellular carcinoma/Loss of heterozygosity/Clonal origin/Prognosis引用本文复制引用
QianZhao,WenLongYu,XinYuanLu,HuiDong,YiJinGu,XiaSheng,WenMingCong,and MengChao Wu..Combined hepatocellular andcholangiocarcinoma originating fromthe same clone：a pathomolecular evidence-based study[J].癌症（英文版）,2016,56(11):585-595,11.
